SI-BONE (SIBN) to Release Earnings on Monday

SI-BONE (NASDAQ:SIBN) is projected to announce its earnings results after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $48.87 million for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

SI-BONE Stock Down 0.1 %

SIBN stock opened at $16.39 on Monday. The firm has a market cap of $687.40 million, a PE ratio of -17.82 and a beta of 1.17. The company has a debt-to-equity ratio of 0.22, a quick ratio of 7.22 and a current ratio of 8.25. The firm’s fifty day moving average is $15.26 and its 200 day moving average is $14.55. SI-BONE has a one year low of $11.70 and a one year high of $21.19.

Analysts Set New Price Targets

Several analysts recently commented on SIBN shares. Needham & Company LLC restated a “buy” rating and set a $19.00 price target on shares of SI-BONE in a research report on Monday, January 13th. Truist Financial raised their price target on shares of SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Six research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $23.00.

Insider Buying and Selling at SI-BONE

In other news, CFO Anshul Maheshwari sold 5,304 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $13.91, for a total value of $73,778.64. Following the transaction, the chief financial officer now directly owns 189,319 shares of the company’s stock, valued at approximately $2,633,427.29. This trade represents a 2.73 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Anthony J. Recupero sold 3,670 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $13.90, for a total transaction of $51,013.00. Following the completion of the transaction, the insider now directly owns 222,814 shares in the company, valued at approximately $3,097,114.60. This represents a 1.62 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 9,311 shares of company stock valued at $130,356 over the last ninety days. Corporate insiders own 3.90% of the company’s stock.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.